Kevin Waters - 15 Mar 2024 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
EVP, CFO
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters
Issuer symbol
PRCT
Transactions as of
15 Mar 2024
Net transactions value
+$243,692
Form type
4
Filing time
18 Mar 2024, 18:05:18 UTC
Previous filing
19 Apr 2024
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Options Exercise $162,765 +36,010 +73% $4.52 85,426 15 Mar 2024 Direct
transaction PRCT Common Stock Options Exercise $80,926 +17,747 +21% $4.56 103,173 15 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -36,010 -69% $0.000000 15,917 15 Mar 2024 Common Stock 36,010 $4.52 Direct F1
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -17,747 -25% $0.000000 53,243 15 Mar 2024 Common Stock 17,747 $4.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option was granted on October 23, 2018 and vested over a four year period.
F2 The Stock option was granted on December 12, 2019 and vested over a four year period.